8,215 Shares of Intuitive Surgical, Inc. $ISRG Bought by St. Louis Financial Planners Asset Management LLC

St. Louis Financial Planners Asset Management LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 8,215 shares of the medical equipment provider’s stock, valued at approximately $3,098,000. Intuitive Surgical makes up 1.3% of St. Louis Financial Planners Asset Management LLC’s investment portfolio, making the stock its 25th biggest position.

Other large investors have also modified their holdings of the company. TD Waterhouse Canada Inc. lifted its holdings in Intuitive Surgical by 15.9% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 39,455 shares of the medical equipment provider’s stock worth $15,822,000 after buying an additional 5,422 shares during the last quarter. KFG Wealth Management LLC grew its position in shares of Intuitive Surgical by 3.2% in the 3rd quarter. KFG Wealth Management LLC now owns 978 shares of the medical equipment provider’s stock worth $398,000 after acquiring an additional 30 shares in the last quarter. James T. Borello RIA increased its holdings in shares of Intuitive Surgical by 63.1% in the 3rd quarter. James T. Borello RIA now owns 106 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 41 shares during the last quarter. Pension & Wealth Management Advisors Inc. increased its holdings in shares of Intuitive Surgical by 76.9% in the 3rd quarter. Pension & Wealth Management Advisors Inc. now owns 1,433 shares of the medical equipment provider’s stock valued at $583,000 after acquiring an additional 623 shares during the last quarter. Finally, Daytona Street Capital LLC increased its holdings in shares of Intuitive Surgical by 657.2% in the 3rd quarter. Daytona Street Capital LLC now owns 7,845 shares of the medical equipment provider’s stock valued at $3,177,000 after acquiring an additional 6,809 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, EVP Mark Brosius sold 77 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the transaction, the executive vice president owned 881 shares of the company’s stock, valued at approximately $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the executive vice president directly owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. This trade represents a 6.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock valued at $4,891,989 in the last three months. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $1.16 during midday trading on Friday, reaching $426.70. 2,609,555 shares of the company traded hands, compared to its average volume of 2,090,678. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The firm has a market capitalization of $150.74 billion, a price-to-earnings ratio of 48.88, a price-to-earnings-growth ratio of 3.23 and a beta of 1.46. The company has a fifty day moving average price of $391.43 and a 200 day moving average price of $409.74.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period in the prior year, the business earned $1.81 EPS. The firm’s revenue was up 18.4% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Piper Sandler reissued an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, August 21st. UBS Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Tuesday. Royal Bank Of Canada dropped their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday, July 13th. HSBC downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. Finally, Citigroup reduced their price target on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $498.83.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts at Erste Group Bank raised their earnings estimates for ISRG, suggesting improved expectations for the company’s upcoming results and longer-term profitability. Erste Group Bank Analysts Boost Earnings Estimates for ISRG
• Positive Sentiment: Recent results have shown double-digit growth in robotic-surgery procedures, revenue and Intuitive Surgical’s installed base of systems. That underlying operating momentum remains a key support for the investment case despite the stock’s broader underperformance this year. Intuitive Surgical Valuation and Growth
• Positive Sentiment: The shares increased in the prior session and outperformed the broader market that day, reflecting some investor support ahead of the earnings release. ISRG Beats Stock Market Upswing
• Neutral Sentiment: Investors are focused on third-quarter procedure growth, da Vinci system demand, revenue, margins and other operating metrics—not just earnings per share and revenue—to determine whether recent momentum is sustainable. ISRG Ahead of Q3 Earnings
• Negative Sentiment: Expectations are tempered by slowing U.S. procedure growth and headwinds in China. These issues could pressure system placements and margins, increasing the risk of an earnings-related market reaction. ISRG Q3 Earnings Preview
• Negative Sentiment: Despite double-digit growth, shares have declined substantially during 2026 and trade at a premium valuation. Investors are questioning whether a valuation around 33 times expected earnings adequately reflects the company’s growth prospects, particularly if procedure growth slows. ISRG Valuation Analysis

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.